We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Jones Lang LaSalle
JLL
$16.7B
| $6.57M | 0.06% |
41,110
+31,586
| +332% | +$5M |
|
327
Agilent Technologies
A
$39.9B
| $6.49M | 0.06% |
155,325
-902,801
| -85% | -$34.9M |
|
|
PF
328
DELISTED
Pinnacle Foods, Inc.
PF
| $6.49M | 0.06% |
+152,849
| New | +$6.54M |
|
329
Autodesk
ADSK
$51.2B
| $6.47M | 0.06% |
+106,143
| New | +$6.17M |
|
|
DPLO
330
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $6.34M | 0.06% |
+185,427
| New | +$5.79M |
|
331
PayPal
PYPL
$51.1B
| $6.27M | 0.06% |
173,282
-184,022
| -52% | -$6.49M |
|
332
Alkermes
ALKS
$8.11B
| $6.26M | 0.06% |
78,879
-106,836
| -58% | -$7.48M |
|
333
Green Plains
GPRE
$1.06B
| $6.17M | 0.06% |
+269,585
| New | +$5.71M |
|
334
Group 1 Automotive
GPI
$3.23B
| $6.14M | 0.06% |
+81,072
| New | +$6.71M |
|
|
SUM
335
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6.12M | 0.06% |
318,431
-78,664
| -20% | -$1.6M |
|
|
GHDX
336
DELISTED
Genomic Health, Inc.
GHDX
| $6.1M | 0.06% |
+173,219
| New | +$4.64M |
|
337
Radian Group
RDN
$4.82B
| $6.01M | 0.06% |
449,070
+114,487
| +34% | +$1.68M |
|
|
SF
338
Stifel
SF
$12.6B
| $6M | 0.06% |
+318,897
| New | +$6.2M |
|
|
CRC
339
DELISTED
California Resources Corporation
CRC
| $5.99M | 0.06% |
257,185
+111,682
| +77% | +$4.02M |
|
|
ATHN
340
DELISTED
Athenahealth, Inc.
ATHN
| $5.99M | 0.06% |
37,199
+24,284
| +188% | +$3.75M |
|
341
Best Buy
BBY
$16.9B
| $5.96M | 0.06% |
+195,896
| New | +$6.48M |
|
342
Phillips 66
PSX
$82.4B
| $5.93M | 0.06% |
72,532
+64,332
| +785% | +$5.55M |
|
|
WPX
343
DELISTED
WPX Energy, Inc.
WPX
| $5.93M | 0.06% |
1,032,400
-1,133,854
| -52% | -$8.43M |
|
344
Dine Brands
DIN
$450M
| $5.88M | 0.06% |
+69,429
| New | +$5.95M |
|
|
SPN
345
DELISTED
Superior Energy Services, Inc.
SPN
| $5.8M | 0.05% |
43,027
+20,671
| +92% | +$3.07M |
|
346
TAL Education Group
TAL
$6.91B
| $5.76M | 0.05% |
+743,616
| New | +$5.07M |
|
|
JAH
347
DELISTED
JARDEN CORPORATION
JAH
| $5.76M | 0.05% |
100,810
+84,672
| +525% | +$4.24M |
|
348
HF Sinclair
DINO
$14.7B
| $5.71M | 0.05% |
+143,208
| New | +$6.78M |
|
349
Eli Lilly
LLY
$1.06T
| $5.7M | 0.05% |
67,607
-515,198
| -88% | -$42.8M |
|
350
American Tower
AMT
$79.8B
| $5.69M | 0.05% |
58,700
+56,019
| +2,089% | +$5.46M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.